Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vomeronasal 1 receptor 25 pseudogene (VN1R25P) is a human genomic locus annotated as a pseudogene, meaning it contains sequence similarity to functional vomeronasal 1 receptors but does not encode a functional protein. Vomeronasal receptors are G protein-coupled receptors typically implicated in pheromone detection in other vertebrates, but in humans, most VN1R gene family members are non-functional. VN1R25P is not a protein-coding gene, does not serve as a receptor, and has no known molecular or clinical roles[1][3][5]. It is catalogued in genome databases and may be referenced for evolutionary or population genetics, but is not actionable in therapeutic research or drug development. No current evidence supports any clinical, biomarker, drug interaction, or mechanism-of-action relevance for VN1R25P, and its listing in gene and protein databases is purely descriptive of genomic structure and evolutionary ancestry.
None applicable. No drugs target the VN1R25P pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal 1 receptor 25 pseudogene (VN1R25P).